HOME › DRUGS › VEDOLIZUMAB
ACTIVE SUBSTANCE / INN

VEDOLIZUMAB

Brand name(s): Entyvio, ENTYVIO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125476
Colitis, Ulcerative;Crohn Disease
ACTIVE SUBSTANCE
Vedolizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
TAKEDA PHARMS USA, Takeda Pharma A/S
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ENTYVIOBLA125476TAKEDA PHARMS USAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EntyvioTakeda Pharma A/SAuthorised22/05/2014Colitis, Ulcerative;Crohn Disease

FULL INTELLIGENCE ON VEDOLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →